| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |